Abeona Therapeutics Inc. (ABEO) Revenue History
Annual and quarterly revenue from 1995 to present
ABEO Revenue Over Time (1995–2025)
ABEO Revenue Growth History
13 of 26 years with positive growth- FY1995 revenue growth
- N/A
- FY1996 revenue growth
- -94.3%
- FY1997 revenue growth
- +160.5%
- FY1998 revenue growth
- -77.0%
- FY1999 revenue growth
- -85.0%
- FY2000 revenue growth
- +613.3%
- FY2001 revenue growth
- +127.1%
- FY2002 revenue growth
- +372.0%
- FY2003 revenue growth
- +12.9%
- FY2004 revenue growth
- -57.6%
- FY2005 revenue growth
- -100.0%
- FY2006 revenue growth
- N/A
- FY2007 revenue growth
- N/A
- FY2008 revenue growth
- +410.5%
- FY2009 revenue growth
- +21.0%
- FY2010 revenue growth
- +36.6%
- FY2011 revenue growth
- +284.2%
- FY2012 revenue growth
- +138.3%
- FY2013 revenue growth
- -53.6%
- FY2014 revenue growth
- -54.7%
- FY2015 revenue growth
- +12.4%
- FY2016 revenue growth
- -14.5%
- FY2017 revenue growth
- -5.8%
- FY2018 revenue growth
- +258.2%
- FY2019 revenue growth
- -100.0%
- FY2020 revenue growth
- N/A
- FY2021 revenue growth
- -70.0%
- FY2022 revenue growth
- -52.9%
- FY2023 revenue growth
- +147.5%
- FY2024 revenue growth
- -100.0%
- FY2025 revenue growth
- N/A
| Quarter | Revenue | YoY |
|---|---|---|
| Q1 2026 | $8.7M | — |
| Q4 2025 | $5.4M | — |
| Q3 2025 | $0 | — |
| Q2 2025 | $400K | — |
| Q1 2025 | $0 | — |
| Q4 2024 | $0 | — |
| Q3 2024 | $0 | — |
| Q2 2024 | $0 | -100.0% |
Multi-year avg. share of annual revenue by fiscal quarter
Revenue Breakdown (FY 2025)
ABEO's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
ABEO Revenue Analysis (1995–2025)
Current Revenue & Growth
As of June 23, 2026, Abeona Therapeutics Inc. (ABEO) generated trailing twelve-month (TTM) revenue of $14.5 million. The most recent quarter (Q1 2026) recorded $8.7 million in revenue, up 60.9% sequentially.
Historical Growth Trajectory
ABEO's 5-year compound annual growth rate (CAGR) stands at -10.3%, indicating revenue contraction over this period. The 3-year CAGR of +60.3% exceeds the 5-year average, indicating an acceleration in the most recent period. Abeona Therapeutics Inc.'s highest annual revenue of $10.0 million was recorded in 2020.
Revenue by Segment
ABEO's revenue is primarily driven by License (58%), and Product (42%). With over half of revenue concentrated in License, the company has a focused business model while developing other growth vectors.
Peer Comparison
Compared to Healthcare sector peers — including KRYS (+25.1% YoY), RARE (+13.3% YoY), and FOLD (+20.0% YoY). Compare ABEO vs KRYS →
ABEO Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| ABEOCurrent | $15M | - | -10.3% | -1536.9% | |
 KRYS | $389M | +25.1% | - | 41.5% | |
 RARE | $673M | +13.3% | +19.9% | -79.5% | |
 FOLD | $634M | +20.0% | +19.4% | 5.4% | |
 ACAD | $1.1B | +9.9% | +19.4% | 9.8% |
ABEO Historical Revenue Data (1995–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $5.8M | - | $4.3M | 73.7% | $-89,448,000 | -1536.9% |
| 2024 | $0 | -100.0% | $-2,907,000 | - | $-64,211,000 | - |
| 2023 | $3.5M | +147.5% | $1.9M | 54.1% | $-47,135,000 | -1346.7% |
| 2022 | $1.4M | -52.9% | $964K | 68.2% | $-50,915,000 | -3600.8% |
| 2021 | $3.0M | -70.0% | $3.0M | 100.0% | $-89,836,000 | -2994.5% |
| 2020 | $10.0M | - | $10.0M | 100.0% | $-81,420,000 | -814.2% |
| 2019 | $0 | -100.0% | $-48,566,000 | - | $-77,090,000 | - |
| 2018 | $3.0M | +258.2% | $-35,700,000 | -1190.8% | $-58,166,000 | -1940.2% |
| 2017 | $837K | -5.8% | $-16,152,000 | -1929.7% | $-27,836,000 | -3325.7% |
| 2016 | $889K | -14.5% | $-9,766,000 | -1098.5% | $-23,881,000 | -2686.3% |
| 2015 | $1.0M | +12.4% | $1.0M | 100.0% | $-18,546,000 | -1783.3% |
| 2014 | $925K | -54.7% | $925K | 100.0% | $-3,131,000 | -338.5% |
| 2013 | $2.0M | -53.6% | $1.9M | 93.9% | $-3,804,000 | -186.3% |
| 2012 | $4.4M | +138.3% | $4.1M | 93.9% | $-4,316,000 | -98.0% |
| 2011 | $1.8M | +284.2% | $632K | 34.2% | $-7,876,000 | -426.2% |
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
31+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ABEO — Frequently Asked Questions
Quick answers to the most common questions about buying ABEO stock.
Is ABEO's revenue growth accelerating or slowing?
ABEO TTM revenue: $15M. YoY growth: N/A. 5-year CAGR: -10.3%.
What is ABEO's revenue history from 1995 to 2026?
Abeona Therapeutics Inc. (ABEO) revenue history spans 1995 to 2026. TTM revenue as of 2026 is $15M, growing at N/A YoY. The 5-year CAGR is -10.3%. Complete annual and quarterly revenue figures are available on this page, including gross profit, operating income, and margin trends.
What is ABEO's long-term revenue growth rate (CAGR)?
Abeona Therapeutics Inc.'s 5-year revenue CAGR of -10.3% reflects the variable nature of its business expansion. As of 2026, the current YoY growth rate of N/A is in line with this long-term average. CAGR is the most reliable measure of sustained revenue momentum for ABEO.
Why does ABEO's quarterly revenue fluctuate?
ABEO quarterly revenue can fluctuate significantly between periods. A quarter-over-quarter (QoQ) change does not always indicate a trend; comparing the same quarter year-over-year (YoY) is a more reliable signal for underlying growth. Abeona Therapeutics Inc.'s revenue data from 1995 to 2026 shows full historical quarterly detail on this page.
How is ABEO's revenue distributed by segment?
ABEO reports revenue broken down by product line and geographic region. The segment breakdown on this page shows which business units contribute the most to total revenue as of the latest fiscal year. Concentration in a single segment above 50% indicates category dependence, while a diversified mix signals more resilient revenue streams.
How does ABEO's revenue compare to industry peers?
Abeona Therapeutics Inc. (ABEO) with TTM revenue of $15M and N/A YoY growth can be benchmarked against sector peers using the comparison table on this page. Revenue growth relative to peers indicates market share gains or losses. The peer section shows TTM revenue, YoY growth, and operating margin for direct comparisons.